Infection Surveillance Systems Market Overview
The Infection Surveillance Systems Market was valued at USD 575.5 Million in 2025 and is projected to reach USD 2.04 Billion by 2032, growing at a CAGR of 15.1% during 2026–2032, with North America holding the largest share.
Primary Drivers
- Rising incidence of healthcare-associated infections and antimicrobial resistance is forcing hospitals to deploy real-time electronic surveillance and stewardship platforms.
- Regulatory reporting mandates and reimbursement penalties tied to HAI rates (CMS, NHSN and equivalent programmes) make surveillance software effectively compulsory for acute-care providers.
- Widespread EHR adoption plus AI/analytics-driven early-warning capability and post-pandemic outbreak preparedness funding are accelerating procurement.
Primary Challenges
- High upfront licensing, implementation and integration costs make surveillance platforms difficult to justify for small and rural hospitals.
- Interoperability barriers with fragmented legacy EHR, LIS and pharmacy systems complicate deployment and data quality.
- Data privacy and security obligations, alert fatigue from false positives, and shortages of trained infection preventionists and informatics staff limit realised value.
This report includes a dedicated chapter covering supply chain exposure, export controls, sanctions risk, and regulatory shifts affecting Infection Surveillance Systems Market.
Infection Surveillance Systems Market Strategic Outlook
Infection Surveillance Systems is designed to support decision making in infection prevention and control (IPC) programs by improving surveillance practices. Hospital-acquired infections (HAIs) have become serious concern globally. It occurs in at least 48 hours into a patient’s hospital stay that were neither present nor incubating at the time of patient admission. HAIs are critical safety concerns for patients, healthcare professionals and healthcare systems. Infection surveillance system has emerged as support to evidence-based prevention and control programs to reduce HAI prevalence.
Growth trajectory, 2026–2032
How this market is covered
Revenue split by type
Revenue by end use
Increasing occurrences of Hospital-acquired infections (HAIs) globally is main force driving Infection surveillance System Market. United States Infection surveillance System Market is expected to cross USD 600 million by 2024 holds almost 60% of market shares. Infection surveillance System is also emerging very rapidly in Europe, China, Japan, India and South Korea.
Infection Surveillance Systems is need for accurate diagnosis of Hospital-acquired infections (HAIs). Infection surveillance systems information can inform prioritization of infection prevention efforts. World Health Organization (WHO) offers simplified definition of HAI to use in limited context for clinical diagnosis. United States Centers for Disease Control and Prevention (CDC) also offers standardized HAI definitions to follow in United States. A multi-disciplinary HAI steering committee has developed new Infection surveillance System which satisfies WHO definitions and collect accurate infection data. The use of electronic surveillance systems (ESSs) also used in many hospitals to control -acquired infections (HAIs).
Infection Surveillance Systems on downside :
- Requires prolonged surveillance
- Varied majorly in accordance to treatment.
- Challenging to implement in many low to middle-income countries (LMICs)
- Microbiology laboratory and IT infrastructure requires
- Patient records may be incomplete, inconsistent and hence unusable in Infection surveillance System.
Surgical site infections, which can occur up to thirty days post-operatively, may be difficult to conduct. These challenges may lead to non- or under-detection of HAI’s with resultant missed opportunities to institute the appropriate medical treatment. In LMICs prevalence of HAIs ranges from 5% to 70% among hospitalized patients, with surgical site infections being the most common. Highest HAI rates were found in intensive care unit (ICU), Neonatal ICU and Orthopedics / burn unit .
Important applications of Infection Surveillance Systems:
- Hospitals
- Clinics
- Home Cares
- Sanitation
Global Infection Surveillance Systems Market: Product Type Analysis
- Hardware
- Software
- Services
Global Infection Surveillance Systems Market: Solutions
- Web Based
- Training & Consulting
- Implementation
On Premise
Infection Surveillance Systems Market : Competitive Analysis
Report includes accurate analysis of key players with Market Value, Company profile, SWOT analysis. The Study consists of following key players in Infection surveillance System Market :
- BD Medical
- Premier
- Wolters Kluwer
- Baxter International
- GOJO Industries
- Atlas Medical Software
- Deb Group
- Hygreen
- RL Solutions
- Truven Health Analytics
Global Infection Surveillance Systems Market: Regional Analysis
-
North America
- U.S.A
- Canada
- Europe
- France
- Germany
- Spain
- UK
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South East Asia
- Latin America
- Brazil
- Middle East and Africa
Diagnostics Landscape
Report Coverage
| Parameter | Details |
|---|---|
| Base Year | 2025 |
| Historical Data | 2020 – 2025 |
| Forecast Period | 2026 – 2032 |
| Base Year Value | USD 575.5 Million |
| Forecast Value | USD 2.04 Billion |
| CAGR | 15.1% |
| Regional Scope | North America · Europe · Asia-Pacific · Latin America · MEA · RoW |
Frequently Asked Questions
Infection Surveillance Systems Market was valued at USD 575.5 Million in 2025 and is estimated to reach USD 2.04 Billion by 2032.
Infection Surveillance Systems Market is projected to grow at a CAGR of 15.1% during 2025–2032.
United States Infection surveillance System Market is expected to reach USD 600 million by 2024 holds almost 60% of market shares.
Some of the top key players of the Infection Surveillance System Market are BD Medical,Premier,Wolters Kluwer,Baxter International,GOJO Industries,Atlas Medical Software,Deb Group,Hygreen,RL Solutions,Truven Health Analytics
1. Rising incidence of healthcare-associated infections and antimicrobial resistance is forcing hospitals to deploy real-time electronic surveillance and stewardship platforms. 2. Regulatory reporting mandates and reimbursement penalties tied to HAI rates (CMS, NHSN and equivalent programmes) make surveillance software effectively compulsory for acute-care providers. 3. Widespread EHR adoption plus AI/analytics-driven early-warning capability and post-pandemic outbreak preparedness funding are accelerating procurement.
Yes. The report includes a dedicated section on geopolitical risk factors and their impact on supply chains, pricing, and regional demand dynamics.